
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
---|---|---|---|---|---|
HUN
Huntsman
|
$1.5B | -$0.12 | -0.67% | -72.72% | $13.12 |
ALB
Albemarle
|
$1.2B | -$0.77 | -13.89% | -96.45% | $82.54 |
BCPC
Balchem
|
$250.3M | $1.25 | 6.94% | 27.55% | $196.00 |
CC
The Chemours
|
$1.6B | $0.46 | 1.6% | 13.03% | $15.11 |
PZG
Paramount Gold Nevada
|
-- | -$0.02 | -- | -33.33% | $1.70 |
XPL
Solitario Resources
|
-- | -$0.02 | -- | -100% | $1.50 |
Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
---|---|---|---|---|---|---|---|
HUN
Huntsman
|
$11.30 | $13.12 | $2B | -- | $0.25 | 8.85% | 0.33x |
ALB
Albemarle
|
$70.41 | $82.54 | $8.3B | 43.27x | $0.41 | 2.3% | 1.63x |
BCPC
Balchem
|
$158.14 | $196.00 | $5.2B | 37.92x | $0.87 | 0.55% | 5.37x |
CC
The Chemours
|
$13.25 | $15.11 | $2B | 69.74x | $0.09 | 6.32% | 0.34x |
PZG
Paramount Gold Nevada
|
$0.68 | $1.70 | $48.7M | -- | $0.00 | 0% | -- |
XPL
Solitario Resources
|
$0.66 | $1.50 | $58.8M | -- | $0.00 | 0% | -- |
Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
---|---|---|---|---|
HUN
Huntsman
|
39.84% | -0.355 | 66.34% | 0.73x |
ALB
Albemarle
|
26.09% | 1.819 | 32.87% | 1.20x |
BCPC
Balchem
|
13.58% | 0.793 | 3.51% | 1.29x |
CC
The Chemours
|
87.64% | 2.100 | 202.85% | 0.79x |
PZG
Paramount Gold Nevada
|
-- | 1.260 | -- | -- |
XPL
Solitario Resources
|
-- | 0.385 | -- | -- |
Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
---|---|---|---|---|---|---|
HUN
Huntsman
|
$201M | $10M | -3.02% | -4.78% | 3.26% | -$110M |
ALB
Albemarle
|
$156.3M | $18.7M | -7.93% | -10.51% | 2.79% | $362.8M |
BCPC
Balchem
|
$88.2M | $51M | 9.89% | 11.92% | 20.3% | $30.9M |
CC
The Chemours
|
$236M | $78M | 0.66% | 4.67% | 4.83% | -$196M |
PZG
Paramount Gold Nevada
|
-$185.4K | -$2.2M | -- | -- | -- | -$1.6M |
XPL
Solitario Resources
|
-$7K | -$736K | -- | -- | -- | -$598K |
Albemarle has a net margin of -0.36% compared to Huntsman's net margin of 3.84%. Huntsman's return on equity of -4.78% beat Albemarle's return on equity of -10.51%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
HUN
Huntsman
|
14.26% | -$0.03 | $5.1B |
ALB
Albemarle
|
14.51% | -- | $13.8B |
Huntsman has a consensus price target of $13.12, signalling upside risk potential of 16.07%. On the other hand Albemarle has an analysts' consensus of $82.54 which suggests that it could grow by 17.23%. Given that Albemarle has higher upside potential than Huntsman, analysts believe Albemarle is more attractive than Huntsman.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
HUN
Huntsman
|
1 | 12 | 1 |
ALB
Albemarle
|
6 | 15 | 2 |
Huntsman has a beta of 0.706, which suggesting that the stock is 29.382% less volatile than S&P 500. In comparison Albemarle has a beta of 1.627, suggesting its more volatile than the S&P 500 by 62.719%.
Huntsman has a quarterly dividend of $0.25 per share corresponding to a yield of 8.85%. Albemarle offers a yield of 2.3% to investors and pays a quarterly dividend of $0.41 per share. Huntsman pays -92.06% of its earnings as a dividend. Albemarle pays out -26.39% of its earnings as a dividend.
Huntsman quarterly revenues are $1.4B, which are larger than Albemarle quarterly revenues of $1.1B. Huntsman's net income of -$5M is lower than Albemarle's net income of $41.3M. Notably, Huntsman's price-to-earnings ratio is -- while Albemarle's PE ratio is 43.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Huntsman is 0.33x versus 1.63x for Albemarle. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
HUN
Huntsman
|
0.33x | -- | $1.4B | -$5M |
ALB
Albemarle
|
1.63x | 43.27x | $1.1B | $41.3M |
Balchem has a net margin of -0.36% compared to Huntsman's net margin of 14.79%. Huntsman's return on equity of -4.78% beat Balchem's return on equity of 11.92%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
HUN
Huntsman
|
14.26% | -$0.03 | $5.1B |
BCPC
Balchem
|
35.19% | $1.13 | $1.4B |
Huntsman has a consensus price target of $13.12, signalling upside risk potential of 16.07%. On the other hand Balchem has an analysts' consensus of $196.00 which suggests that it could grow by 23.94%. Given that Balchem has higher upside potential than Huntsman, analysts believe Balchem is more attractive than Huntsman.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
HUN
Huntsman
|
1 | 12 | 1 |
BCPC
Balchem
|
0 | 0 | 0 |
Huntsman has a beta of 0.706, which suggesting that the stock is 29.382% less volatile than S&P 500. In comparison Balchem has a beta of 0.891, suggesting its less volatile than the S&P 500 by 10.888%.
Huntsman has a quarterly dividend of $0.25 per share corresponding to a yield of 8.85%. Balchem offers a yield of 0.55% to investors and pays a quarterly dividend of $0.87 per share. Huntsman pays -92.06% of its earnings as a dividend. Balchem pays out 19.91% of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Huntsman quarterly revenues are $1.4B, which are larger than Balchem quarterly revenues of $250.5M. Huntsman's net income of -$5M is lower than Balchem's net income of $37.1M. Notably, Huntsman's price-to-earnings ratio is -- while Balchem's PE ratio is 37.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Huntsman is 0.33x versus 5.37x for Balchem. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
HUN
Huntsman
|
0.33x | -- | $1.4B | -$5M |
BCPC
Balchem
|
5.37x | 37.92x | $250.5M | $37.1M |
The Chemours has a net margin of -0.36% compared to Huntsman's net margin of -0.29%. Huntsman's return on equity of -4.78% beat The Chemours's return on equity of 4.67%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
HUN
Huntsman
|
14.26% | -$0.03 | $5.1B |
CC
The Chemours
|
17.25% | -$0.03 | $4.7B |
Huntsman has a consensus price target of $13.12, signalling upside risk potential of 16.07%. On the other hand The Chemours has an analysts' consensus of $15.11 which suggests that it could grow by 14.05%. Given that Huntsman has higher upside potential than The Chemours, analysts believe Huntsman is more attractive than The Chemours.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
HUN
Huntsman
|
1 | 12 | 1 |
CC
The Chemours
|
4 | 4 | 0 |
Huntsman has a beta of 0.706, which suggesting that the stock is 29.382% less volatile than S&P 500. In comparison The Chemours has a beta of 1.652, suggesting its more volatile than the S&P 500 by 65.152%.
Huntsman has a quarterly dividend of $0.25 per share corresponding to a yield of 8.85%. The Chemours offers a yield of 6.32% to investors and pays a quarterly dividend of $0.09 per share. Huntsman pays -92.06% of its earnings as a dividend. The Chemours pays out 172.09% of its earnings as a dividend.
Huntsman quarterly revenues are $1.4B, which are larger than The Chemours quarterly revenues of $1.4B. Huntsman's net income of -$5M is lower than The Chemours's net income of -$4M. Notably, Huntsman's price-to-earnings ratio is -- while The Chemours's PE ratio is 69.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Huntsman is 0.33x versus 0.34x for The Chemours. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
HUN
Huntsman
|
0.33x | -- | $1.4B | -$5M |
CC
The Chemours
|
0.34x | 69.74x | $1.4B | -$4M |
Paramount Gold Nevada has a net margin of -0.36% compared to Huntsman's net margin of --. Huntsman's return on equity of -4.78% beat Paramount Gold Nevada's return on equity of --.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
HUN
Huntsman
|
14.26% | -$0.03 | $5.1B |
PZG
Paramount Gold Nevada
|
-- | -$0.04 | -- |
Huntsman has a consensus price target of $13.12, signalling upside risk potential of 16.07%. On the other hand Paramount Gold Nevada has an analysts' consensus of $1.70 which suggests that it could grow by 149.19%. Given that Paramount Gold Nevada has higher upside potential than Huntsman, analysts believe Paramount Gold Nevada is more attractive than Huntsman.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
HUN
Huntsman
|
1 | 12 | 1 |
PZG
Paramount Gold Nevada
|
1 | 0 | 0 |
Huntsman has a beta of 0.706, which suggesting that the stock is 29.382% less volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.135, suggesting its more volatile than the S&P 500 by 13.451%.
Huntsman has a quarterly dividend of $0.25 per share corresponding to a yield of 8.85%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Huntsman pays -92.06% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend.
Huntsman quarterly revenues are $1.4B, which are larger than Paramount Gold Nevada quarterly revenues of --. Huntsman's net income of -$5M is lower than Paramount Gold Nevada's net income of -$2.6M. Notably, Huntsman's price-to-earnings ratio is -- while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Huntsman is 0.33x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
HUN
Huntsman
|
0.33x | -- | $1.4B | -$5M |
PZG
Paramount Gold Nevada
|
-- | -- | -- | -$2.6M |
Solitario Resources has a net margin of -0.36% compared to Huntsman's net margin of --. Huntsman's return on equity of -4.78% beat Solitario Resources's return on equity of --.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
HUN
Huntsman
|
14.26% | -$0.03 | $5.1B |
XPL
Solitario Resources
|
-- | -$0.01 | -- |
Huntsman has a consensus price target of $13.12, signalling upside risk potential of 16.07%. On the other hand Solitario Resources has an analysts' consensus of $1.50 which suggests that it could grow by 128.94%. Given that Solitario Resources has higher upside potential than Huntsman, analysts believe Solitario Resources is more attractive than Huntsman.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
HUN
Huntsman
|
1 | 12 | 1 |
XPL
Solitario Resources
|
0 | 0 | 0 |
Huntsman has a beta of 0.706, which suggesting that the stock is 29.382% less volatile than S&P 500. In comparison Solitario Resources has a beta of 0.465, suggesting its less volatile than the S&P 500 by 53.534%.
Huntsman has a quarterly dividend of $0.25 per share corresponding to a yield of 8.85%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Huntsman pays -92.06% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend.
Huntsman quarterly revenues are $1.4B, which are larger than Solitario Resources quarterly revenues of --. Huntsman's net income of -$5M is lower than Solitario Resources's net income of -$511K. Notably, Huntsman's price-to-earnings ratio is -- while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Huntsman is 0.33x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
HUN
Huntsman
|
0.33x | -- | $1.4B | -$5M |
XPL
Solitario Resources
|
-- | -- | -- | -$511K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.